The Zurich city government and the Zurich University Hospital said on Wednesday that the Federal Office of Public Health approved the conditions for the organic production of two separate strains of cannabis.
The project, Zuri Can – Cannabis with Responsibility, is intended to study the impact of regulated cannabis supply on the consumption and health of consumers.
The project was delayed last October following objections by the health office.
Control groups
The sale of cannabis products from pharmacies and social clubs to control groups is now due to begin next August.
A maximum of 2,100 participants can take part in the large-scale pilot project in Switzerland’s biggest city.
A first trial with about 400 participants was launched in the city of Basel last year, following a legal amendment by the Swiss parliament in 2020 allowing for trials to study the impact of the use of cannabis for recreational use.
Swiss Fairtrade label breaks billion franc barrier in sales
This content was published on
Products with the Fairtrade Max Havelaar label generated sales of more than CHF1 billion in Switzerland for the first time last year.
Swatch shareholders reject board bid by Steven Wood
This content was published on
At the Swiss watchmaker’s Annual General Meeting on Wednesday, 79.2% of votes cast opposed his election to the supervisory board.
WHO members agree to 20% rise in mandatory contributions
This content was published on
If the resolution is backed in the plenary session, the organisation’s budget for 2026-2027 will rise to CHF4.2 billion ($5.1 billion).
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.